An in silico structural insights into Plasmodium LytB protein and its inhibition

Journal of Biomolecular Structure and Dynamics

Volumn 33, Issue 6, 2015, Pages 1198-1210

  Bhuyan, Rajabrata ^a   Nandy, Suman Kumar ^a   Seal, Alpana ^a  

^a UNIVERSITY OF KALYANI   (India)

Author keywords

drug target; IspH; LytB; non mevalonate pathway; virtual screening

Indexed keywords

ANTIMALARIAL AGENT; ENZYME INHIBITOR; LIGAND; PROTOZOAL PROTEIN;

AMINO ACID SEQUENCE; ANTAGONISTS AND INHIBITORS; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; DRUG DEVELOPMENT; ENZYMOLOGY; HYDROGEN BOND; MOLECULAR DOCKING; MOLECULAR DYNAMICS; MOLECULAR GENETICS; PLASMODIUM; PROTEIN DOMAIN; PROTEIN STABILITY; SEQUENCE ALIGNMENT; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANTIMALARIALS; DRUG DISCOVERY; ENZYME INHIBITORS; HYDROGEN BONDING; LIGANDS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MOLECULAR DOCKING SIMULATION; MOLECULAR DYNAMICS SIMULATION; MOLECULAR SEQUENCE DATA; PLASMODIUM; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN STABILITY; PROTOZOAN PROTEINS; SEQUENCE ALIGNMENT; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84939884063     PISSN: 07391102     EISSN: 15380254     Source Type: Journal    
DOI: 10.1080/07391102.2014.938248     Document Type: Article

References (71)

1. Altschul, S. F., Madden, T. L., Schäffer, A. A., Zhang, J., Zhang, Z., Miller, W., Lipman, D. J. (1997). Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic acids research, 25, 3389-3402.
2. Banerjee, A. K., Arora, N., Murty, U. S. N. (2009). Structural model of the Plasmodium falciparum Thioredoxin reductase: A novel target for antimalarial drugs. Journal of Vector Borne Diseases, 46, 171-183. Retrieved from http://www.mrcindia.org/
3. Berendsen, H. J. C., Grigera, J. R., Straatsma, T. P. (1987). The missing term in effective pair potentials. The Journal of Physical Chemistry, 91, 6269-6271.
4. Bloch, K. (1992). Sterol molecule: Structure, biosynthesis, and function. Steroids, 57, 378-383.
5. Bolton, E. E., Wang, Y., Thiessen, P. A., Bryant, S. H. (2008). PubChem: Integrated platform of small molecules and biological activities. Annual Reports in Computational Chemistry, 4, 217-241.
6. Borrmann, S., Adegnika, A. A., Moussavou, F., Oyakhirome, S., Esser, G., Matsiegui, P. B.,., Kremsner, P. G. (2005). Short-course regimens of artesunate-fosmidomycin in treatment of uncomplicated Plasmodium falciparum malaria. Antimicrobial Agents and Chemotherapy, 49, 3749-3754.
7. Borrmann, S., Lundgren, I., Oyakhirome, S., Impouma, B., Matsiegui, P. B., Adegnika, A. A.,., Kremsner, P. G. (2006). Fosmidomycin plus clindamycin for treatment of pediatric patients aged 1 to 14 years with Plasmodium falciparum malaria. Antimicrobial Agents and Chemotherapy, 50, 2713-2718.
8. Bouvier, F., dHarlingue, A., Suire, C., Backhaus, R. A., Camara, B. (1998). Dedicated roles of plastid transketolases during the early onset of isoprenoid biogenesis in pepper fruits1. Plant Physiology, 117, 1423-1431.
9. Bryson, K., McGuffin, L. J., Marsden, R. L., Ward, J. J., Sodhi, J. S., Jones, D. T. (2005). Protein structure prediction servers at University College London. Nucleic Acids Research, 33, W36-W38.
10. Bussi, G., Donadio, D., Parrinello, M. (2007). Canonical sampling through velocity rescaling. The Journal of Chemical Physics, 126, 014101.
11. Chappell, J. (1995). Biochemistry and molecular biology of the isoprenoid biosynthetic pathway in plants. Annual Review of Plant Physiology and Plant Molecular Biology, 46, 521-547.
12. Christianson, D. W. (2008). Unearthing the roots of the terpenome. Current Opinion in Chemical Biology, 12, 141-150.
13. Colovos, C., Yeates, T. O. (1993). Verification of protein structures: Patterns of nonbonded atomic interactions. Protein Science, 2, 1511-1519.
14. Cox, F. E. G. (1988). Major animal models in malaria research: Rodent. In W. H. Wernsdorfer, & I. McGregor. (Eds.), Malaria: Principles and practice of malariology (pp. 1503-1543). London: Churchill Livingstone.
15. Croteau, R., Kutchan, T. M., Lewis, N. G. (2000). Natural products (secondary metabolites). In B. Buchanan, W. Gruissem, R. Jones, & M. Dekker. (Eds.), Biochemistry & molecular biology of plants (pp. 1250-1318). New York, NY: American Society of Plant Physiologists.
16. Darden, T., York, D., Pedersen, L. (1993). Particle mesh Ewald: An Nslog(N) method for Ewald sums in large systems. The Journal of Chemical Physics, 98, 10089-10092.
17. Davis, I. W., Leaver-Fay, A., Chen, V. B., Block, J. N., Kapral, G. J., Wang, X.,., Richardson, D. C. (2007). MolProbity: All-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Research, 35, W375-W383.
18. Eisenreich, W., Rohdich, F., Bacher, A. (2001). Deoxyxylulose phosphate pathway to terpenoids. Trends in Plant Science, 6, 78-84.
19. Eisenreich, W., Schwarz, M., Cartayrade, A., Arigoni, D., Zenk, M. H., Bacher, A. (1998). The deoxyxylulose phosphate pathway of terpenoid biosynthesis in plants and microorganisms. Chemistry & Biology, 5, R221-R233.
20. Espinosa, E., Belmant, C., Pont, F., Luciani, B., Poupot, R., Romagné, F.,., Fournié, J. J. (2001). Chemical synthesis and biological activity of bromohydrin pyrophosphate, a potent stimulator of human gamma delta T Cells. Journal of Biological Chemistry, 276, 18337-18344.
21. Eswar, N., Eramian, D., Webb, B., Shen, M. Y., Sali, A. (2008). Protein structure modeling with MODELLER. Methods in Molecular Biology, 426, 145-159.
22. Goldstein, J. L., Brown, M. S. (1990). Regulation of the mevalonate pathway. Nature, 343, 425-430.
23. Gräwert, T., Rohdich, F., Span, I., Bacher, A., Eisenreich, W., Eppinger, J., Groll, M. (2009). Structure of active IspH enzyme from Escherichia coli provides mechanistic insights into substrate reduction. Angewandte Chemie International Edition, 48, 5756-5759.
24. Gräwert, T., Span, I., Bacher, A., Groll, M. (2010). Reductive dehydroxylation of allyl alcohols by IspH protein. Angewandte Chemie International Edition, 49, 8802-8809.
25. Gräwert, T., Span, I., Eisenreich, W., Rohdich, F., Eppinger, J., Bacher, A., Groll, M. (2010). Probing the reaction mechanism of IspH protein by X-ray structure analysis. Proceedings of the National Academy of Sciences, 107, 1077-1081.
26. Hale, I., ONeill, P. M., Berry, N. G., Odom, A., Sharma, R. (2012). The MEP pathway and the development of inhibitors as potential anti-infective agents. Med Chem Comm, 3, 418-433.
27. Hess, B., Bekker, H., Berendsen, H. J., Fraaije, J. G. (1997). LINCS: A linear constraint solver for molecular simulations. Journal of computational chemistry, 18, 1463-1472.
28. Hess, B., Kutzner, C., van der Spoel, D., Lindahl, E. (2008). GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation. Journal of Chemical Theory and Computation, 4, 435-447.
29. Hooft, R. W., Vriend, G., Sander, C., Abola, E. E. (1996). Errors in protein structures. Nature, 381, 272.
30. Hyde, J. E. (2007). Drug-resistant malaria-An insight. FEBS Journal, 274, 4688-4698.
31. Jones, G., Willett, P., Glen, R. C., Leach, A. R., Taylor, R. (1997). Development and validation of a genetic algorithm for flexible docking. Journal of Molecular Biology, 267, 727-748.
32. Kazuta, Y., Tagaya, M., Tanizawa, K., Fukui, T. (1993). Probing the pyrophosphate-binding site in potato tuber UDP-glucose pyrophosphorylase with pyridoxal diphosphate. Protein Science, 2, 119-125.
33. Lange, B. M., Wildung, M. R., McCaskill, D., Croteau, R. (1998). A family of transketolases that directs isoprenoid biosynthesis via a mevalonate-independent pathway. Proceedings of the National Academy of Sciences, 95, 2100-2104. Retrieved from http://www.pnas.org/10.1073/pnas.95.5.2100
34. Larkin, M. A., Blackshields, G., Brown, N. P., Chenna, R., McGettigan, P. A., McWilliam, H.,., Higgins, D. G. (2007). Clustal W and Clustal X version 2.0. Bioinformatics, 23, 2947-2948.
35. Laskowski, R. A., MacArthur, M. W., Moss, D. S., Thornton, J. M. (1993). PROCHECK: A program to check the stereochemical quality of protein structures. Journal of Applied Crystallography, 26, 283-291.
36. Laupitz, R., Gräwert, T., Rieder, C., Zepeck, F., Bacher, A., Arigoni, D.,., Eisenreich, W. (2004). Stereochemical studies on the making and unmaking of isopentenyl diphosphate in different biological systems. Chemistry & Biodiversity, 1, 1367-1376.
37. Lipinski, C. A., Lombardo, F., Dominy, B. W., Feeney, P. J. (2012). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 64, 4-17.
38. Liu, Y. L., Guerra, F., Wang, K., Wang, W., Li, J., Huang, C.,., Oldfield, E. (2012). Structure, function and inhibition of the two-and three-domain 4Fe-4S IspG proteins. Proceedings of the National Academy of Sciences, 109, 8558-8563.
39. Lois, L. M., Campos, N., Putra, S. R., Danielsen, K., Rohmer, M., Boronat, A. (1998). Cloning and characterization of a gene from Escherichia coli encoding a transketolase-like enzyme that catalyzes the synthesis of D-1-deoxyxylulose 5-phosphate, a common precursor for isoprenoid, thiamin, and pyridoxol biosynthesis. Proceedings of the National Academy of Sciences, 95, 2105-2110. Retrieved from http://www.pnas.org/10.1073/pnas.95.5.2105
40. Lüthy, R., Bowie, J. U., Eisenberg, D. (1992). Assessment of protein models with three-dimensional proles. Nature, 356, 83-85.
41. MacKerell, A. D., Bashford, D., Bellott, M., Dunbrack, R. L., Evanseck, J. D., Field, M. J.,., Karplus, M. (1998). All-atom empirical potential for molecular modeling and dynamics studies of proteins. The Journal of Physical Chemistry B, 102, 3586-3616.
42. Macreadie, I., Ginsburg, H., Sirawaraporn, W., Tilley, L. (2000). Antimalarial drug development and new targets. Parasitology Today, 16, 438-444.
43. Maltman, K. L., Neuhard, J., Warren, R. A. J. (1981). 5-[(Hydroxymethyl)-O-pyrophosphoryl]uracil, an intermediate in the biosynthesis of alpha.-putrescinylthymine in deoxyribonucleic acid of bacteriophage.vphi.W-14. Biochemistry, 20, 3586-3591.
44. Missinou, M. A., Borrmann, S., Schindler, A., Issifou, S., Adegnika, A. A., Matsiegui, P. B.,., Kremsner, P. G. (2002). Fosmidomycin for malaria. The Lancet, 360, 1941-1942.
45. Mongélard, G., Seemann, M., Boisson, A., Rohmer, M., Bligny, R., Rivasseau, C. (2011). Measurement of carbon flux through the MEP pathway for isoprenoid synthesis by 31P-NMR spectroscopy after specific inhibition of 2-C-methyl-d-erythritol 2, 4-cyclodiphosphate reductase. Effect of light and temperature. Plant, Cell & Environment, 34, 1241-1247.
46. Muehlbacher, M., Poulter, C. D. (1988). Isopentenyl-diphosphate isomerase: Inactivation of the enzyme with active-site-directed irreversible inhibitors and transition state analogs. Biochemistry, 27, 7315-7328.
47. Nyland II, R. L., II, Xiao, Y., Liu, P., Freel Meyers, C. L. (2009). IspG converts an epoxide substrate analogue to (E)-4-hydroxy-3-methylbut-2-enyl diphosphate: Implications for IspG catalysis in isoprenoid biosynthesis. Journal of the American Chemical Society, 131, 17734-17735.
48. Parrinello, M., Rahman, A. (1981). Polymorphic transitions in single crystals: A new molecular dynamics method. Journal of Applied physics, 52, 7182-7190.
49. Pettifer, S., Sinnott, J. R., Attwood, T. K. (2004). CINEMA-A UTOPIAn sequence editor (Version 1.4.5) [Computer software]. Retrieved from http://utopia.cs.man.ac.uk/utopia/
50. Pontius, J., Richelle, J., Wodak, S. J. (1996). Deviations from standard atomic volumes as a quality measure for protein crystal structures. Journal of Molecular Biology, 264, 121-136.
51. Popjak, G., Parker, T. S., Sarin, V., Tropp, B. E., Engel, R. (1978). Inhibition of 5-phosphomevalonate kinase by an isosteric analog of 5-phosphomevalonate. Journal of the American Chemical Society, 100, 8014-8016.
52. Qiu, Y., Li, D. (2006). Bifunctional inhibitors of mevalonate kinase and mevalonate 5-diphosphate decarboxylase. Organic Letters, 8, 1013-1016.
53. Ramachandran, G. N., Sasisekharan, V. (1968). Conformation of polypeptides and proteins. In C. B. Annsen, M. L. Anson, J. T. Edsall, & F. M. Richards. (Eds.), Advances in protein chemistry (pp. 283-437). New York, NY: Elsevier.
54. Rekittke, I., Wiesner, J., Rohrich, R., Demmer, U., Warkentin, E., Xu, W.,., Ermler, U. (2008). Structure of (E)-4-hydroxy-3-methyl-but-2-enyl diphosphate reductase, the terminal enzyme of the non-mevalonate pathway. Journal of the American Chemical Society, 130, 17206-17207.
55. Rohdich, F., Hecht, S., Gärtner, K., Adam, P., Krieger, C., Amslinger, S.,., Eisenreich, W. (2002). Studies on the nonmevalonate terpene biosynthetic pathway: Metabolic role of IspH (LytB) protein. Proceedings of the National Academy of Sciences, 99, 1158-1163.
56. Rohmer, M. (1999). The discovery of a mevalonate-independent pathway for isoprenoid biosynthesis in bacteria, algae and higher plants†. Natural Product Reports, 16, 565-574.
57. Ruyck, J. D., Wouters, J. (2008). Structure-based drug design targeting biosynthesis of isoprenoids: A crystallographic state of the art of the involved enzymes. Current Protein & Peptide Science, 9, 117-137.
58. Sacchettini, J. C., Poulter, C. D. (1997). Creating isoprenoid diversity. Science, 277, 1788-1789.
59. Seemann, M., Janthawornpong, K., Schweizer, J., Bottger, L. H., Janoschka, A., Ahrens-Botzong, A.,., Rohmer, M. (2009). Isoprenoid biosynthesis via the MEP pathway: in vivo Mossbauer spectroscopy identifies a [4Fe-4S]2+ center with unusual coordination sphere in the LytB protein. Journal of the American Chemical Society, 131, 13184-13185.
60. Seemann, M., Rohmer, M. (2007). Isoprenoid biosynthesis via the methylerythritol phosphate pathway: GcpE and LytB, two novel iron-sulphur proteins. Comptes Rendus Chimie, 10, 748-755.
61. Sippl, M. J. (1995). Knowledge-based potentials for proteins. Current Opinion in Structural Biology, 5, 229-235.
62. Sprenger, G. A., Schörken, U., Wiegert, T., Grolle, S., De Graaf, A. A., Taylor, S. V.,., Sahm, H. (1997). Identification of a thiamin-dependent synthase in Escherichia coli required for the formation of the 1-deoxy-D-xylulose 5-phosphate precursor to isoprenoids, thiamin, and pyridoxol. Proceedings of the National Academy of Sciences, 94, 12857-12862. Retrieved from http://www.pnas.org/10.1073/pnas.94.24.12857
63. Taylor-Robinson, A. W. (1995). Regulation of immunity to malaria: Valuable lessons learned from murine models. Parasitology Today, 11, 334-342.
64. von Grotthuss, M., Pas, J., Rychlewski, L. (2003). Ligand-Info, searching for similar small compounds using index profiles. Bioinformatics, 19, 1041-1042.
65. Wang, W., Li, J., Wang, K., Huang, C., Zhang, Y., Oldfield, E. (2010). Organometallic mechanism of action and inhibition of the 4Fe-4S isoprenoid biosynthesis protein GcpE (IspG). Proceedings of the National Academy of Sciences, 107, 11189-11193.
66. Wang, W., Li, J., Wang, K., Smirnova, T. I., Oldfield, E. (2011). Pyridine inhibitor binding to the 4Fe-4S protein A. aeolicus IspH (LytB): A HYSCORE Investigation. Journal of the American Chemical Society, 133, 6525-6528.
67. Wang, W., Wang, K., Li, J., Nellutla, S., Smirnova, T. I., Oldfield, E. (2011). An ENDOR and HYSCORE investigation of a reaction intermediate in IspG (GcpE) catalysis. Journal of the American Chemical Society, 133, 8400-8403.
68. Wang, W., Wang, K., Liu, Y. L., No, J. H., Li, J., Nilges, M. J., Oldfield, E. (2010). Bioorganometallic mechanism of action, and inhibition, of IspH. Proceedings of the National Academy of Sciences, 107, 4522-4527.
69. Williams, S. L., Andrew McCammon, J. (2009). Conformational dynamics of the flexible catalytic loop in mycobacterium tuberculosis 1-deoxy-d-xylulose 5-phosphate reductoisomerase. Chemical Biology & Drug Design, 73, 26-38.
70. Witschel, M. C., Höffken, H. W., Seet, M., Parra, L., Mietzner, T., Thater, F.,., Diederich, F. (2011). Inhibitors of the herbicidal target IspD: Allosteric site binding. Angewandte Chemie International Edition, 50, 7931-7935.
71. Wouters, J., Oudjama, Y., Stalon, V., Droogmans, L., Poulter, C. D. (2004). Crystal structure of the C67A mutant of isopentenyl diphosphate isomerase complexed with a mechanism-based irreversible inhibitor. Proteins: Structure, Function, and Bioinformatics, 54, 216-221.